Sanchez-Montoya E, Reyes M, Pardo J, Nunez-Alarcon J, Ortiz J, Jorge J
Front Pharmacol. 2017; 8:494.
PMID: 28798689
PMC: 5527703.
DOI: 10.3389/fphar.2017.00494.
Abid H, Ahmad F, Lee S, Park H, Im D, Ahmad I
Behav Brain Funct. 2016; 12(1):31.
PMID: 27899123
PMC: 5126868.
DOI: 10.1186/s12993-016-0115-y.
Lee J, Jo D, Park D, Young Chung H, Mattson M
Pharmacol Rev. 2014; 66(3):815-68.
PMID: 24958636
PMC: 4081729.
DOI: 10.1124/pr.113.007757.
Romano A, Quinn J, Li L, Dave K, Schindler E, Aloyo V
Psychopharmacology (Berl). 2010; 212(3):441-8.
PMID: 20827462
DOI: 10.1007/s00213-010-2004-7.
Harvey J
Learn Mem. 2003; 10(5):355-62.
PMID: 14557608
PMC: 218001.
DOI: 10.1101/lm.60803.
On the antagonism of ergot alkaloids and dopamine by phenothiazines.
Stone T
Experientia. 1974; 30(7):827-9.
PMID: 4847689
DOI: 10.1007/BF01924213.
Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.
Klock J, Boerner U, Becker C
West J Med. 1974; 120(3):183-8.
PMID: 4816396
PMC: 1129381.
Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King A, Martin I, Melville K
Br J Pharmacol. 1974; 52(3):419-26.
PMID: 4458849
PMC: 1777004.
DOI: 10.1111/j.1476-5381.1974.tb08611.x.
The nature of the binding between LSD and a 5-HT receptor: a possible explanation for hallucinogenic activity.
Berridge M, Prince W
Br J Pharmacol. 1974; 51(2):269-78.
PMID: 4375525
PMC: 1776744.
DOI: 10.1111/j.1476-5381.1974.tb09657.x.
Visual hallucinations. Clinical occurrence and use in differential diagnosis.
Cummings J, Miller B
West J Med. 1987; 146(1):46-51.
PMID: 3825109
PMC: 1307180.
Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.
Mittman S, Geyer M
Psychopharmacology (Berl). 1991; 105(1):69-76.
PMID: 1745714
DOI: 10.1007/BF02316866.
Screening hallucinogenic drugs: systematic study of three behavioral tests.
Silva M, Calil H
Psychopharmacologia. 1975; 42(2):163-71.
PMID: 1080571
DOI: 10.1007/BF00429548.
Effects of para-methoxyamphetamine and 2,5-dimethoxyamphetamine on serotonergic mechanisms.
TSENG L
Naunyn Schmiedebergs Arch Pharmacol. 1978; 304(2):101-5.
PMID: 581302
DOI: 10.1007/BF00495545.
A mathematical theory of visual hallucination patterns.
Ermentrout G, Cowan J
Biol Cybern. 1979; 34(3):137-50.
PMID: 486593
DOI: 10.1007/BF00336965.
Screening hallucinogenic drugs II. Systematic study of two behavioral tests.
Calil H
Psychopharmacology (Berl). 1978; 56(1):87-92.
PMID: 415331
DOI: 10.1007/BF00571414.
Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats.
Nozaki M, Bell J, Vaupel D, Martin W
Psychopharmacology (Berl). 1977; 55(1):13-8.
PMID: 414256
DOI: 10.1007/BF00432811.
The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin R, Benington F, Mitchell S, Beaton J, Bradley R, SMYTHIES J
Experientia. 1975; 31(1):93-5.
PMID: 234850
DOI: 10.1007/BF01924697.
Hallucinogen-induced rotational behavior in rats.
Fleisher L, Glick S
Psychopharmacology (Berl). 1979; 62(2):193-200.
PMID: 111284
DOI: 10.1007/BF00427136.
Effects of LSD-25 on avoidance behavior and locomotor activity in mice.
Castellano C
Psychopharmacology (Berl). 1979; 62(2):145-9.
PMID: 111278
DOI: 10.1007/BF00427128.
An analysis of some perceptual effects of morphine, chlorpromazine, and LSD.
Hernandez L, Appel J
Psychopharmacology (Berl). 1979; 60(2):125-30.
PMID: 106422
DOI: 10.1007/BF00432282.
